10.1002/ejoc.201700621
European Journal of Organic Chemistry
FULL PAPER
Methyl 4-(1-(4-methylphenylsulfonamido)ethyl)benzoate (5e). The
title compound was prepared from methyl 4-(1-hydroxyethyl)benzoate
(90 mg) following the general procedure B with a reaction temperature
set to 50°C. The crude product was then purified with a hexane/EtOAc
eluent (80:20) to afford an amorphous white solid. 153 mg (92%). 1H
NMR (400 MHz, CDCl3, 25 °C): δ = 7.83-7.79 (m, 2 H), 7.60-7.57 (m, 2
H), 7.19-7.16 (m, 2 H), 7.13-7.11 (m, 2 H), 5.67 (d, J = 7.4 Hz, 1 H), 4.49
(app quin, J = 7.0 Hz, 1 H), 3.88 (s, 3 H), 2.34 (s, 3 H), 1.38 (d, J = 7.0
Hz, 3 H) ppm; 13C NMR (100 MHz, CDCl3, 25 °C): δ = 166.8, 147.3,
143.3, 137.5, 129.8, 129.5, 129.1, 127.0, 126.2, 53.4, 52.1, 23.5, 21.4
ppm; IR (neat) 3252, 1721, 1432, 1322, 1285, 1153, 1115, 1083 cm-1;
HRMS (ESI) [M+Na]+ calcd for C17H19NNaO4S 356.0932, found 356.0925.
N,4-dimethylbenzenesulfonamide (465 mg) following the general
procedure C and was purified with an hexane/DCM (25:75) eluent to
afford an amorphous white solid. 148 mg (96%). 1H NMR (400 MHz,
CDCl3, 25 °C): δ = 7.73-7.70 (m, 2 H), 7.36-7.34 (m, 2 H), 7.31-7.28 (m,
2 H), 7.26-7.23 (m, 2 H), 4.09 (s, 1 H), 2.57 (s, 1 H), 2.45 (s, 1 H) ppm;
13C NMR (100 MHz, CDCl3, 25 °C): δ = 143.6, 134.3, 134.2, 133.7, 129.8,
129.7, 128.8, 127.5, 53.5, 34.4, 21.6 ppm.
N-(1-(4-Bromophenyl)ethyl)-N,4-dimethylbenzenesulfonamide (6b).
The title compound was prepared from 1-(4-bromophenyl)ethanol (102
mg) and N,4-dimethylbenzenesulfonamide (460 mg) following the
general procedure C. The reaction was performed at room temperature
and monitored by TLC. The crude product was purified with an
hexane/DCM (25:75) eluent to afford an amorphous white solid. 176 mg
(96%). 1H NMR (500 MHz, CDCl3, 25 °C): δ = 7.76-7.73 (m, 2 H), 7.47-
7.44 (m, 2 H), 7.35-7.33 (m, 2 H), 7.21-7.18 (m, 2 H), 5.25 (q, J = 7.0 Hz,
1 H), 2.58 (s, 3 H), 2.46 (s, 3 H), 1.28 (d, J = 7.0 Hz, 3 H) ppm; 13C NMR
(100 MHz, CDCl3, 25 °C): δ = 143.3, 139.1, 137.0, 131.5, 129.8, 129.0,
127.1, 121.6, 54.3, 28.4, 21.5, 15.1 ppm; IR (solid) 2983, 1485, 1337,
1167, 933, 818, 742, 656 cm-1; HRMS (ESI) [M+Na]+ calcd for
C16H18BrNNaO2S 390.0139, found 390.0132.
N-(1-(3-Bromophenyl)ethyl)-4-methylbenzenesulfonamide (5f). The
title compound was prepared from 1-(3-bromophenyl)ethanol (102 mg)
following the general procedure B and was purified with an hexane/DCM
(25:75) eluent to afford an amorphous white solid. 161 mg (90%). 1H
NMR (500 MHz, CDCl3, 25 °C): δ = 7.58-7.56 (m, 2 H), 7.29-7.26 (m, 1
H), 7.18-7.17 (m, 2 H), 7.10 (app s, 1 H), 7.06-7.06 (m, 2 H), 4.84 (d, J =
6.9 Hz, 1 H), 4.45 (app quin, J = 6.9 Hz, 1 H), 2.39 (s, 3 H), 1.40 (d, J =
6.9 Hz, 3 H) ppm; 13C NMR (100 MHz, CDCl3, 25 °C): δ = 144.2, 143.4,
137.3, 130.4, 130.0, 129.5, 129.4, 127.0, 124.9, 122.5, 53.2, 23.5, 21.5
ppm; IR (cast film, DCM) 3273, 1597, 1433, 1325, 1160, 1091, 813, 666
cm-1; HRMS (ESI) [M+Na]+ calcd for C15H16BrNNaO2S 375.9983, found
375.9974.
N-(4-Bromobenzyl)-4-methoxybenzenesulfonamide (6c). The title
compound was prepared from (4-bromophenyl)methanol (95 mg) and 4-
methoxybenzenesulfonamide (470 mg) following the general procedure
C and was purified with an hexane/DCM (25:75) eluent to afford an
amorphous white solid. 111 mg (62%). 1H NMR (500 MHz, CDCl3,
25 °C): δ = 7.78-7.75 (m, 2 H), 7.39-7.37 (m, 2 H), 7.08-7.06 (m, 2H),
6.96-6.94 (m, 2 H), 4.89 (t, J = 6.3 Hz, 1 H), 4.06 (d, J = 6.3 Hz, 2 H),
3.87 (s, 3 H) ppm; 13C NMR (100 MHz, CDCl3, 25 °C): δ = 163.0, 135.6,
131.6, 131.3, 129.6, 129.2, 121.6, 114.3, 55.7, 46.5 ppm; IR (solid) 3270,
1595, 1577, 1307, 1262, 1155, 1030, 804 cm-1; HRMS (ESI) [M–H]–
calcd for C14H13BrNO3S 353.9805, found 353.9799.
N-(1-(2-Bromophenyl)ethyl)-4-methylbenzenesulfonamide (5g). The
title compound was prepared from 1-(2-bromophenyl)ethanol (102 mg)
following the general procedure B and was purified with an hexane/DCM
(25:75) eluent to afford an amorphous white solid. 159 mg (90%). 1H
NMR (500 MHz, CDCl3, 25 °C): δ = 7.65-7.64 (m, 2 H), 7.37 (dd, J = 8.0,
1.3 Hz, 1 H), 7.24 (dd, J = 7.8, 1.7 Hz, 1 H), 7.14-7.12 (m, 2 H), 7.10 (dd,
J = 7.6, 1.3 Hz, 1 H), 6.98 (td, J = 7.6, 1.7 Hz, 1 H), 5.72 (d, J = 7.4 Hz, 1
H), 4.88 (app quin, J = 7.0 Hz, 1 H), 2.34 (s, 3 H), 1.38 (d, J = 6.9 Hz, 3
H) ppm; 13C NMR (125 MHz, CDCl3, 25 °C): δ = 143.2, 141.3, 137.1,
132.8, 129.4, 128.5, 127.8, 127.7, 127.1, 122.0, 53.0, 23.0, 21.5 ppm. IR
(cast film, DCM) 3279, 1444, 1324, 1161, 1092, 1024, 958, 756 cm-1;
HRMS (ESI) [M+Na]+ calcd for C15H16BrNNaO2S 375.9983, found
375.9972.
N-(4-Bromobenzyl)-2-nitrobenzenesulfonamide
(6d).
The
title
compound was prepared from (4-bromophenyl)methanol (94 mg) and 2-
nitrobenzenesulfonamide (505 mg) following the general procedure C.
The reaction was performed at 100 °C with a reaction time of 24 hours.
The crude product was purified with an hexane/DCM (50:50 to 75:25)
1
eluent to afford an amorphous white solid. 102 mg (55%). H NMR (500
N-Benzhydryl-4-methylbenzenesulfonamide
(5h).10f
The
title
MHz, CDCl3, 25 °C): δ = 7.97 (dd, J = 7.8, 1.5 Hz, 1 H), 7.83 (dd, J = 7.9,
1.4 Hz, 1 H), 7.71 (td, J = 7.7, 1.5 Hz, 1 H), 7.65 (td, J = 7.7, 1.4 Hz, 1 H),
7.36-7.34 (m, 2 H), 7.11-7.10 (m, 2 H), 5.75 (t, J = 6.5 Hz, 1 H), 4.28 (d, J
= 6.4 Hz, 2 H) ppm; 13C NMR (125 MHz, CDCl3, 25 °C): δ = 147.8, 134.9,
133.9, 133.5, 132.8, 131.8, 130.9, 129.5, 125.3, 122.0, 47.2 ppm; IR
(solid) 3341, 3100, 1592, 1543, 1487, 1438, 1358, 1204, 1070, 1009, 738
cm-1; HRMS (ESI) [M–H]– calcd for C13H10BrN2O4S 368.9550, found
368.9547.
compound was prepared from diphenylmethanol (benzhydrol) (92 mg)
following the general procedure B with 2 mL of a HFIP/nitromethane (4:1)
solvent. It was then purified with an hexane/DCM (25:75) eluent to afford
an amorphous white solid. 163 mg (96%). 1H NMR (400 MHz, CDCl3,
25 °C): δ = 7.58-7.55 (m, 2 H), 7.22-7.19 (m, 6 H), 7.14-7.09 (m, 6 H),
5.57 (d, J = 7.0 Hz, 1 H), 5.10 (d, J = 7.1 Hz, 1 H), 2.38 (s, 3 H) ppm; 13
C
NMR (100 MHz, CDCl3, 25 °C): δ = 143.2, 140.5, 137.4, 129.4, 128.5,
127.6, 127.4, 127.2, 61.3, 21.5 ppm.
N-(2-Bromo-4-fluorobenzyl)-N-methyl-2-nitrobenzenesulfonamide
General procedure C for the catalytic sulfonamidation of benzyl
alcohols with various sulfonamides: Without any other specification,
the reaction conditions for the direct catalytic sulfonamidation of benzylic
alcohols were the following ones. Benzylic alcohol derivative (0.50 mmol),
sulfonamides (2.50 mmol), 2,3,4,5-tetrafluorophenylboronic acid BA1
(10.0 mg, 0.050 mmol) and oxalic acid dihydrate (6.3 mg, 0.050 mmol)
were added to a mixture of HFIP (1.6 mL) and nitromethane (0.4 mL) in a
sealed tube equipped with a magnetic stirring bar. The reaction media
was stirred at 80 °C for 6 hours. The solvent was then evaporated and
the crude product was purified by flash chromatography on silica gel
using a solid deposit technique (silica).
(6e). The title compound was prepared from (2-bromo-4-
fluorophenyl)methanol
(103
mg)
and
N-methyl-2-
nitrobenzenesulfonamide (540 mg) following the general procedure C
with a reaction time of 24 hours. The crude product was then purified with
an hexane/DCM (25:75) eluent to afford an amorphous white solid. 140
mg (70%). 1H NMR (500 MHz, CDCl3, 25 °C): δ = 8.04-8.02 (m, 1 H),
7.76-7.69 (m, 2 H), 7.69-7.67 (m, 1 H), 7.50 (dd, J = 8.7, 5.9 Hz, 1 H),
7.30 (dd, J = 8.1, 2.6 Hz, 1 H), 7.07 (ddd, J = 8.7, 7.9, 2.6 Hz, 1 H), 4.55
(s, 2 H), 2.86 (s, 3 H) ppm; 13C NMR (125 MHz, CDCl3, 25 °C): δ = 161.9
(JC-F = 251.5 Hz), 148.3 , 133.8 , 132.2 , 131.7 , 131.1 , 130.9 (JC-F = 8.6
Hz), 130.7 (JC-F = 3.5 Hz), 124.3 , 123.6 (JC-F = 9.6 Hz), 120.1 (JC-F
=
24.5 Hz), 115.3 (JC-F = 21.1 Hz), 52.9, 34.7 ppm; IR (cast film, DCM)
3096, 2931, 1589, 1487, 1372, 1168, 925, 763 cm-1; HRMS (ESI)
[M+Na]+ calcd for C14H12BrFN2NaO4S 424.9583, found 424.9583.
N-(4-Chlorobenzyl)-N,4-dimethylbenzenesulfonamide (6a).21 The title
compound was prepared from (4-chlorophenyl)methanol (71 mg) and
This article is protected by copyright. All rights reserved.